References
- Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev 2002; 1: 329–37
- Price P, Mathiot N, Krueger R, Stone S, Keane NM, French MA. Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. J Clin Virol 2001; 22: 279–87
- van der Ven AJ, van Oostenbrugge RJ, Kubat B, Tervaert JW. Cerebral vasculitis after initiation of antiretroviral therapy. AIDS 2002; 16: 2362–4
- Jubault V, Penfornis A, Schillo F, Hoen B, Izembart M, Timsit J, et al. Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromized human immunodeficiency virus-1-infected patients. J Clin Endocrinol Metab 2000; 85: 4254–7
- Sereti I, Sarlis NJ, Arioglu E, Turner ML, Mican JM. Alopecia universalis and Graves' disease in the setting of immune restoration after highly active antiretroviral therapy. AIDS 2001; 15: 138–40
- French MA, Lewin SR, Dykstra C, Krueger R, Price P, Leedman PJ. Graves' disease during immune reconstitution after highly active antiretroviral therapy for HIV infection: evidence of thymic dysfunction. AIDS Res Hum Retroviruses 2004; 20: 157–62
- Wong KH, Chow WS, Lee SS. Clinical hyperthyroidism in Chinese patients with stable HIV disease. Clin Infect Dis 2004; 39: 1257–9
- Fontes R, Vangeloti A, Pires ML, Lima MB, Dimetz T, Faulhaber M, et al. Endocrine disorders in Brazilian patients with acquired immune deficiency syndrome. Clin Infect Dis 2003; 37(Suppl 2)S137–41
- Burch HB, Bernet VJ, Plotkin FR, McCord CF, Howard RS, Solomon BL, et al. Graves' disease in a US Army Special Forces Group. JAMA 2002; 288: 2975–6
- Mostbeck A, Galvan G, Bauer P, Eber O, Atefie K, Dam K, et al. The incidence of hyperthyroidism in Austria from 1987 to 1995 before and after an increase in salt iodization in 1990. Eur J Nucl Med 1987; 1998; 25: 367–74
- Learoyd DL, Fung HY, McGregor AM. Post partum thyroid dysfunction. Thyroid 1992; 2: 73–80
- Davies TF. The thyroid immunology of the post partum period. Thyroid 1999; 9: 675–84
- Regalbuto C, Salamone S, Scollo C, Vigneri R, Pezzino V. Appearance of anti- TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma. J Endocrinol Invest 1999; 22: 147–50
- Cseke B, Balazs C. Development of Basedow disease after radioiodine therapy for nodular goitre. Orv Hetil 2003; 144: 2327–9
- Huysmans, AK, Hermus, RM, Edelbroek, MA, Tjabbes, T, Oostdijk, Ross, HA, , et al. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goitres. Thyroid, 1997;7:535–9.
- Coles AJ, Wing M, Smith S, Coraddu F, Greer S, Taylor C, et al. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 1999; 354: 1691–5
- Monzani F, Caraccio N, Dardano A, Ferrannini E. Thyroid autoimmunity and dysfunction associated with type I interferon therapy. Clin Exp Med 2004; 3: 199–210
- Rotondi M, Lazzeri E, Romagnani P, Serio M. Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. J Endocrinol Invest 2003; 26: 177–80